June 27, 2014 / 2:28 PM / 4 years ago

BUZZ-U.S. Stocks on the Move-Amsurg, Profire, Nextera, Dollar General

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s)

U.S. stocks edged lower at the open on Friday, with materials weighing the most after DuPont lowered its quarterly and yearly outlooks. The Dow Jones industrial average was down 0.19 percent at 16,813.57, the S&P 500 was down 0.09 percent at 1,955.49 and the Nasdaq Composite was down 3.73 points, or 0.09 percent, at 4,375.32.

** DOLLAR GENERAL CORP, $57.621, -6.58 pct

The discount retailer’s CEO Rick Dreiling will retire effective May 30, 2015, or upon appointment of a successor, the company said.

Under Dreiling’s leadership, the company’s sales had increased more than 80 percent to $17.5 billion in 2013.

** AMSURG CORP, $45.1755, -1.36 pct

The ambulatory surgery center operator priced its common stock offering of 8.5 million shares, representing 26 percent of total outstanding shares, at $45 per share. The offer is at a discount of 2 percent to the stock’s Thursday closing on the Nasdaq.

** PROFIRE ENERGY INC, $4.3, -11.34 pct

The combustion management technology developer priced its public offering of 6 million shares at $4 each, a discount of 17.5 pct to the stock’s Thursday close. The offering represents about 12.5 percent of outstanding shares, according to Thomson Reuters data.

** TASEKO MINES LTD, $2.42, +5.22 pct

A Supreme Court of Canada ruling confirmed that the Canadian miner’s New Prosperity Gold-Copper project is located in an area where aboriginal title does not exist.

The court said on Thursday aboriginals in British Columbia can stake a broad claim to traditional territories.

** ISIS PHARMACEUTICALS INC, $35.29, -3.00 pct

An article on investment website seekingalpha.com raised questions about the "long-term tolerability" of the company's cholesterol drug, Kynamro.(bit.ly/1pTwTMa)

FDA approved the drug last year as a treatment for a rare genetic disorder that causes high levels of bad cholesterol.

** KEURIG GREEN MOUNTAIN INC, $125.21, +4.01 pct

Argus Research Co raised the rating on the K-cup coffee pod maker’s stock to “buy” from “hold”, according to Theflyonthewall.com. Keurig said last week it would create 550 new jobs and invest $337 million toward its first-ever cold pod manufacturing facility in Georgia.

** KB HOME, $18, +0.67 pct

The homebuilder reported better-than-expected second quarter profit. The company’s average selling price rose 10 percent to $319,700, while orders were up 5 percent at 2,269 homes.

** PROGRESS SOFTWARE CORP, $24.13, +8.50 pct

The enterprise software maker reported better-than-expected second quarter results.

Brokerage Wedbush raised target price on the company’s stock to $23 from $22.

** NIKE INC, $78.36, +1.95 pct

The world’s largest sportswear maker reported better-than-expected quarterly results, as demand for its apparel and footwear rose in North America and Western Europe after the company spent heavily on marketing ahead of the 2014 soccer World Cup.

At least four brokerages raised their price target on the company’s stock.

** DUPONT, $65, -3.99 pct

The chemicals maker cut its operating profit forecast for the second quarter and the full year, saying sales in its agriculture and performance chemicals units increased at a slower pace than it had expected.

** DELPHI AUTOMOTIVE PLC, $67.94, -0.32 pct

The auto parts maker is now part of the U.S. Senate’s inquiry into the General Motors Co recall, the New York Times reported. A House committee released documents on Thursday that contain exchanges between GM’s engineers and Delphi employees over an ignition switch that they knew was below standard, the paper reported.

Delphi is expected to be subjected to a hearing by the Senate Commerce Committee, the paper said.

** MANITOWOC CO INC, $32.35, +8.89 pct

** TEREX CORP, $40.72, +1.93 pct

Activist investment firm Relational Investors LLC disclosed an 8.5 percent stake in crane and food equipment maker Manitowoc and said that a spin off of the food business from the crane business would maximize shareholder value. (1.usa.gov/1pF5bR2)

At least two brokerages raised the price target on the company’s stock.

Rival Terex’s stock was also up on the news.

** RETROPHIN INC, $10.9901, -6.94 pct

The pharmaceutical company said a patient dosed with its experimental neurological disorder drug was temporarily taken off the treatment after an elevation in liver enzyme levels. Elevated liver enzyme levels may indicate inflammation or damage to cells in the liver.

** IGI LABORATORIES INC, $5.17, -2.64 pct

The generic drug maker priced its common stock offering of 4.7 million shares, representing 10 percent of total outstanding shares, at $5 per share. The offer price was at a discount of 6 percent to the stock’s Thursday closing.

** EMERSON ELECTRIC CO, $67.11, +0.57 pct

The power supplies maker said it was evaluating strategic options for power transmission solutions business, which makes couplings, bearings, conveying components.

Emerson sold its connectivity solutions business to Bel Fuse Inc for $98 million last month.

** AWARE INC, $6.59, +16.02 pct

The imaging software maker declared special cash dividend of $1.75 per share, totaling about $40 million.

** AMEDISYS INC, $15.83, +17.70 pct

The home health and hospice company’s second-quarter forecast topped analysts’ average estimate. The company said it expects revenue of $300-$305 million and adjusted earnings from continuing operations of 15-20 cents per share.

** PETROBRAS SA, $14.78, -0.14 pct

A board member said he may ask Brazil’s securities regulator CVM to sanction the state-run oil and gas producer as it did not inform him and other directors of oil rights purchase plan.

The government will sell as much as 15.2 billion ($6.8 billion) barrels of offshore oil rights to the company, a securities filing revealed. The Brazilian government has a heavy hand in affairs of Petrobras which has become the world’s most indebted and least-profitable major oil company under President Dilma Rousseff.

** ENCANA CORP, $23.78, -0.54 pct

** APOLLO GLOBAL MANAGEMENT LLC, $27.05, +0.37 pct

Canada’s largest natural gas producer said it would sell its Bighorn gas properties in Alberta to Apollo for about C$2 billion ($1.9 billion). The deal includes about 360,000 net acres comprising Encana’s working interests in all pipelines and facilities as well as service arrangements.

** NEXTERA ENERGY PARTNERS LP, $32.04, +28.16 pct

Shares of the limited partnership is expected debut on the New York Stock Exchange after its IPO of 16.3 million shares were priced at $25 per share, top end of the expected price range. The company, which was valued at about $2.33 billion at the IPO price, raised about $407.5 million from the offering.

** MICHAELS COS INC to debut

The crafts retailer is expected to return to the market on Friday after it raised about $472.6 million in its IPO. Michaels priced its shares at $17, the lower end of an expected range, valuing the company at up to $3.45 billion. The company was taken private by Blackstone Group LP and Bain Capital LP for $6 billion in 2006. (Compiled by Amrutha Gayathri in Bangalore; Editing by Joyjeet Das)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below